We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
An image displaying a Newsletter on tablet, laptop & mobile

To continue reading this article, sign up for FREE to

Technology Networks logo


Membership is FREE and provides you with instant access to email newsletters, digital publications, our full content catalogue & more...

AnaSpec Highlights MMP Inhibitors

Read time: Less than a minute

AnaSpec, Eurogentec Group, releases 11 MMP inhibitors to complement our wide offering of MMP SensoLyte® 520 and 490 fluorimetric kits, colorimetric kits, recombinant proteins, and Z-Fish™ antibodies (antibodies specific for zebrafish).

These MMP inhibitors are small molecules and act as either potent broad-spectrum inhibitors or selective inhibitors of MMPs. They can be used as reference compounds for validating new MMP assays, and/or for identifying novel MMP inhibitors.

Matrix metalloproteinases (MMPs) belong to a family of secreted or membrane-associated zinc endopeptidases capable of digesting extracellular matrix components.

They are involved in many aspects of both physiological processes and pathological conditions such as tumor development and metastasis, rheumatoid arthritis. As a result, compounds that inhibit MMP activity are considered promising therapeutic agents.

Google News Preferred Source Add Technology Networks as a preferred Google source to see more of our trusted coverage.